BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boteon YL, Boteon APCS, Attard J, Mergental H, Mirza DF, Bhogal RH, Afford SC. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review. Am J Transplant. 2018;18:2384-2399. [PMID: 29947472 DOI: 10.1111/ajt.14992] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Asong-Fontem N, Panisello-Rosello A, Lopez A, Imai K, Zal F, Delpy E, Rosello-Catafau J, Adam R. A Novel Oxygen Carrier (M101) Attenuates Ischemia-Reperfusion Injuries during Static Cold Storage in Steatotic Livers. Int J Mol Sci 2021;22:8542. [PMID: 34445250 DOI: 10.3390/ijms22168542] [Reference Citation Analysis]
2 Czigany Z, Lurje I, Schmelzle M, Schöning W, Öllinger R, Raschzok N, Sauer IM, Tacke F, Strnad P, Trautwein C, Neumann UP, Fronek J, Mehrabi A, Pratschke J, Schlegel A, Lurje G. Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications. J Clin Med 2020;9:E846. [PMID: 32244972 DOI: 10.3390/jcm9030846] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
3 Miyachi Y, Yagi S, Hirata M, Iwamura S, Yao S, Shirai H, Okumura S, Iida T, Ito T, Uozumi R, Kaido T, Uemoto S. Etiology of Liver Steatosis Influences the Severity of Ischemia/Reperfusion Injury and Survival After Liver Transplantation in Rats. Liver Transpl 2020;26:1504-15. [PMID: 32511857 DOI: 10.1002/lt.25814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lai Q, Ruberto F, Pawlik TM, Pugliese F, Rossi M. Use of machine perfusion in livers showing steatosis prior to transplantation: a systematic review. Updates Surg 2020;72:595-604. [PMID: 32449031 DOI: 10.1007/s13304-020-00797-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Goumard C, Turco C, Sakka M, Aoudjehane L, Lesnik P, Savier E, Conti F, Scatton O. Ex-Vivo Pharmacological Defatting of the Liver: A Review.J Clin Med. 2021;10:1253. [PMID: 33803539 DOI: 10.3390/jcm10061253] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Patrono D, Catalano G, Rizza G, Lavorato N, Berchialla P, Gambella A, Caropreso P, Mengozzi G, Romagnoli R. Perfusate Analysis During Dual Hypothermic Oxygenated Machine Perfusion of Liver Grafts: Correlations With Donor Factors and Early Outcomes. Transplantation 2020;104:1929-42. [PMID: 32769628 DOI: 10.1097/TP.0000000000003398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
7 Liu Z, Wang W, Zhuang L, Liu J, Que S, Zhu D, Dong L, Yu J, Zhou L, Zheng S. Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation. Hepatobiliary Surg Nutr 2020;9:739-58. [PMID: 33299829 DOI: 10.21037/hbsn.2019.12.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Magro B, Tacelli M, Mazzola A, Conti F, Celsa C. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr 2021;10:76-92. [PMID: 33575291 DOI: 10.21037/hbsn.2019.09.01] [Reference Citation Analysis]
9 Boteon YL, Attard J, Boteon APCS, Wallace L, Reynolds G, Hubscher S, Mirza DF, Mergental H, Bhogal RH, Afford SC. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery. Liver Transpl. 2019;25:1007-1022. [PMID: 30821045 DOI: 10.1002/lt.25439] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 43.0] [Reference Citation Analysis]
10 Boteon YL, Boteon AP, Attard J, Wallace L, Bhogal RH, Afford SC. Impact of machine perfusion of the liver on post-transplant biliary complications: A systematic review. World J Transplantation 2018; 8(6): 220-231 [PMID: 30370232 DOI: 10.5500/wjt.v8.i6.220] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Bodewes SB, van Leeuwen OB, Thorne AM, Lascaris B, Ubbink R, Lisman T, Monbaliu D, De Meijer VE, Nijsten MWN, Porte RJ. Oxygen Transport during Ex Situ Machine Perfusion of Donor Livers Using Red Blood Cells or Artificial Oxygen Carriers. Int J Mol Sci 2020;22:E235. [PMID: 33379394 DOI: 10.3390/ijms22010235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Gill MG, Majumdar A. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. World J Hepatol 2020; 12(12): 1168-1181 [PMID: 33442446 DOI: 10.4254/wjh.v12.i12.1168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Croome KP, Lee DD, Taner CB. The “Skinny” on Assessment and Utilization of Steatotic Liver Grafts: A Systematic Review: Liver Transplantation. Liver Transpl 2019;25:488-99. [DOI: 10.1002/lt.25408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
14 Matton APM, Selten JW, Roest HP, de Jonge J, IJzermans JNM, de Meijer VE, Porte RJ, van der Laan LJW. Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers. Clin Transplant 2020;34:e13790. [PMID: 31984571 DOI: 10.1111/ctr.13790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Gao J, He K, Xia Q, Zhang J. Research progress on hepatic machine perfusion. Int J Med Sci 2021;18:1953-9. [PMID: 33850464 DOI: 10.7150/ijms.56139] [Reference Citation Analysis]
16 Boteon YL, Afford SC. Machine perfusion of the liver: Which is the best technique to mitigate ischaemia-reperfusion injury? World J Transplantation 2019; 9(1): 14-20 [PMID: 30697517 DOI: 10.5500/wjt.v9.i1.14] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
17 Liu Z, Jia J, Ning H, Que S, Zhou L, Zheng S. Systematic Evaluation of the Safety Threshold for Allograft Macrovesicular Steatosis in Cadaveric Liver Transplantation. Front Physiol 2019;10:429. [PMID: 31105577 DOI: 10.3389/fphys.2019.00429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Parente A, Osei-Bordom DC, Ronca V, Perera MTPR, Mirza D. Organ Restoration With Normothermic Machine Perfusion and Immune Reaction. Front Immunol 2020;11:565616. [PMID: 33193335 DOI: 10.3389/fimmu.2020.565616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Mazilescu LI, Selzner M, Selzner N. Defatting strategies in the current era of liver steatosis. JHEP Rep 2021;3:100265. [PMID: 34027337 DOI: 10.1016/j.jhepr.2021.100265] [Reference Citation Analysis]
20 Majumdar A, Tsochatzis EA. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Metabolism 2020;111:154291. [DOI: 10.1016/j.metabol.2020.154291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Raigani S, Carroll C, Griffith S, Pendexter C, Rosales I, Deirawan H, Beydoun R, Yarmush M, Uygun K, Yeh H. Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content. PLoS One 2020;15:e0232886. [PMID: 32396553 DOI: 10.1371/journal.pone.0232886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Nostedt JJ, Shapiro J, Freed DH, Bigam DL. Addressing organ shortages: progress in donation after circulatory death for liver transplantation. Can J Surg 2020;63:E135-41. [PMID: 32195556 DOI: 10.1503/cjs.005519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Golse N. AI finally provides augmented intelligence to liver surgeons. EBioMedicine 2020;61:103064. [PMID: 33096474 DOI: 10.1016/j.ebiom.2020.103064] [Reference Citation Analysis]
24 Chen G, Jiang J, Wang X, Yang M, Xie Y, Guo H, Tang H, Zhou L, Hu D, Kamel IR, Chen Z, Li Z. Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF-MRI. Magn Reson Med 2021;85:2805-14. [PMID: 33197060 DOI: 10.1002/mrm.28592] [Reference Citation Analysis]
25 Croome KP, Lee DD, Croome S, Chadha R, Livingston D, Abader P, Keaveny AP, Taner CB. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Am J Transplant 2019;19:2550-9. [DOI: 10.1111/ajt.15330] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
26 Zhao Q, Nie Y, Guo Z, He X. The future of organ-oriented research and treatment. Hepatobiliary Surg Nutr 2019;8:502-5. [PMID: 31673539 DOI: 10.21037/hbsn.2019.08.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]